Research Article
A Corpus-Based Study of Public Attitudes towards Coronavirus Vaccines
Table 3
Neutral collocation of the word “vaccine.”
| Word | Rank | Freq |
| Covid | 3 | 5807 | New | 4 | 5163 | Experimental | 7 | 3859 | Other | 8 | 3112 | Global | 9 | 2535 | Russian | 11 | 1826 | Chinese | 12 | 1722 | Free | 13 | 1420 | Possible | 14 | 1365 | Ready | 15 | 1364 | SINOVAC | 16 | 1291 | Approved | 17 | 1282 | Clinical | 18 | 1211 | National | 19 | 1169 | Two-dose | 20 | 1047 | Different | 22 | 1016 | Largest | 23 | 1015 | Single-dose | 24 | 945 | Current | 25 | 823 | Advisory | 26 | 822 | Early | 29 | 731 | Likely | 30 | 697 | Additional | 31 | 681 | Inactivated | 32 | 680 | Single | 33 | 653 | Indigenous | 35 | 653 | Federal | 36 | 598 | Oral | 37 | 591 | Slow | 39 | 577 | Only | 40 | 575 | International | 41 | 570 | Future | 42 | 568 | Novel | 43 | 551 | Local | 44 | 550 | One-shot | 45 | 546 | One-dose | 51 | 461 | Similar | 52 | 459 | Major | 54 | 446 | Eventual | 55 | 440 | Viral | 56 | 435 | Universal | 57 | 435 | Biggest | 58 | 434 | Investigational | 59 | 412 | Latest | 60 | 412 | Particular | 62 | 407 | Developed | 63 | 407 | Widespread | 64 | 407 | Domestic | 65 | 403 | Mass | 66 | 396 | Two-shot | 67 | 393 | Pandemic | 68 | 392 | High | 69 | 390 | Multiple | 70 | 387 | Live | 71 | 386 | Ongoing | 72 | 360 | Indian | 74 | 355 | Rapid | 75 | 353 | Public | 76 | 352 | Coronvavac | 77 | 352 | Existing | 78 | 348 | Therapeutic | 79 | 341 | Actual | 80 | 340 | Specific | 81 | 340 | Recent | 82 | 334 | Equitable | 83 | 331 | Seasonal | 85 | 327 | Top | 86 | 320 | Proven | 87 | 319 | Developing | 88 | 319 | Sure | 89 | 318 | Recombinant | 91 | 312 | Pneumococcal | 92 | 312 | Various | 93 | 309 | Working | 94 | 298 | GAVI | 95 | 298 | Real | 96 | 289 | Important | 97 | 288 | African | 98 | 280 | Late | 99 | 278 |
|
|